ZIRABEV
Swiss trademark · 681665 · Word mark · In force
Register entry
- Registration number
- 681665
- Application number
- 65480/2015
- Status
- In force
- Type
- Word mark
- Filed
- Dec 9, 2015
- Registered
- Dec 16, 2015
- Published
- Dec 16, 2015
- Protected until
- Dec 9, 2035
- Language of procedure
- German
- Source
- Swissreg
Goods and services
Pharmaceuticals
Pharmazeutische Erzeugnisse für die Behandlung von Krebs.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 5, 2025
Renewed
- Expiry date
- 09.12.2025 → 09.12.2035
Published in Swissreg on 05.09.2025
- Jun 27, 2024
Agent removed
- Representative
- BOVARD SA, Conseils en propriété intellectuelle, Optingenstrasse 16, 3013 Berne (removed)
Published in Swissreg on 27.06.2024
- Jun 27, 2024
Agent entered
- Representative
- E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 27.06.2024
- Aug 23, 2023
Agent removed
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich (removed)
Published in Swissreg on 23.08.2023
- Aug 23, 2023
Agent entered
- Representative
- BOVARD SA, Conseils en propriété intellectuelle, Optingenstrasse 16, 3013 Berne
Published in Swissreg on 23.08.2023
- Aug 23, 2023
Holder’s address changed
- Owner
- Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA → Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001-2192, USA
Published in Swissreg on 23.08.2023
- Mar 21, 2016
Partly deleted
- LGS
- 5, Pharmazeutische Präparate; Hygienepräparate für medizinische Zwecke. → 5, Pharmazeutische Erzeugnisse für die Behandlung von Krebs.
- International classification
- 5 → 5
Published in Swissreg on 21.03.2016
- Dec 16, 2015
Registered
Published in Swissreg on 16.12.2015
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.